![Rodney Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Rodney K.
B. Young worked as Chief Financial Officer at Extropy Pharmaceuticals, Inc. from 2003 to 2005.
From 2005 to 2013, served as Chief Financial Officer, VP & Head-IR at StemCells, Inc. Held the position of Chief Financial Officer at Aimmune Therapeutics, Inc. from 2014 to 2015.
Worked as Chief Financial Officer at Cellerant Therapeutics, Inc. from 2015 to 2019.
Served as Chief Financial Officer & Secretary at Rapt Therapeutics, Inc. from 2019 to 2026.
Completed undergraduate studies at The University of Chicago.
Earned an MBA from The University of Chicago Booth School of Business.
Precedenti posizioni note di Rodney Young
| Società | Posizione | Fine |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Direttore Finanziario/CFO | 03/03/2026 |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Direttore Finanziario/CFO | 01/11/2019 |
| AIMMUNE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/02/2015 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Direttore Finanziario/CFO | 01/12/2013 |
Extropy Pharmaceuticals, Inc. | Direttore Finanziario/CFO | 01/01/2005 |
Formazione di Rodney Young
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Extropy Pharmaceuticals, Inc. | |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
